Pediatric Neuromyelitis Optica Spectrum Disorder (NMOSD) 1 Year Observational Study
Status: Completed
Location: See location...
Study Type: Observational
SUMMARY
This study is being done to develop a database of pediatric patients in order to study the cause, early detection and best treatment for neuromyelitis optica spectrum disorder (NMOSD) in pediatric patients.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 2
Maximum Age: 17
Healthy Volunteers: f
View:
• AQP4 positive
• Ability to give informed consent by patient or caregiver
Locations
United States
Minnesota
Mayo Clinic
Rochester
Time Frame
Start Date: 2018-02-01
Completion Date: 2024-04-03
Participants
Target number of participants: 100
Treatments
Pediatric Neuromyelitis Optica
Participants under the age of 18 that are positive for Aquaporin-4 antibody.
Authors
Related Therapeutic Areas
Sponsors
Leads: Mayo Clinic
Collaborators: Alexion Pharmaceuticals, Inc.